Fundraising Fox
Saros Therapeutics
9 employees on LinkedIn · 1 known investors
Find your way into Saros Therapeutics
Sign up to see every warm intro you have to Saros Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Saros Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
The company develops cancer immunotherapy treatments. Based on the team composition and mission statement, it operates in the biotech and healthcare sectors.
Founders & leadership
RJ
DK
Dominique KendrickCo-Founder, SVP of Regulatory Affairs
PJ
Prof. James MoonCo-Founder, Chief Scientific Officer
PY
Prof. Yu Leo LeiCo-Founder, Clinical and Pre-Clinical Advisor
RP
Robert PetitCo-Founder, Clinical and Pre-Clinical AdvisorRobert Petit is a medical scientist and executive with experience in oncology and immunology drug development across public and private companies. He led U.S. medical efforts for a checkpoint inhibitor immunotherapy through regulatory approval and commercial launch, invented multiple cancer immunotherapies, and oversaw clinical development programs that achieved FDA approval or approvable status.
MM
Matthew MartinCo-Founder, Partner at Pathway Bioventures
Investors · 1
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $1.2M |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Saros Therapeutics do?
- The company develops cancer immunotherapy treatments. Based on the team composition and mission statement, it operates in the biotech and healthcare sectors.
- Who founded Saros Therapeutics?
- Saros Therapeutics was founded by Rich Johnson, Dominique Kendrick, Prof. James Moon, Prof. Yu Leo Lei, Robert Petit, Matthew Martin.
- Who are Saros Therapeutics's investors?
- Saros Therapeutics's investors include SmartHealth Catalyzer.